B vitamin supplementation reduces excretion of urinary dicarboxylic acids in autistic children

Nutrition Research

Volumn 31, Issue 7, 2011, Pages 497-502

  Kałuzna Czaplińska, Joanna ^a   Socha, Ewa ^a   Rynkowski, Jacek ^a  

^a LODZ UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

Autism; Dicarboxylic acids; GC MS; Magnesium; Supplementation; Vitamin B2; Vitamin B6

Indexed keywords

ADIPIC ACID; CREATININE; DICARBOXYLIC ACID; MAGNESIUM; PYRIDOXINE; RIBOFLAVIN; SUBERIC ACID; SUCCINIC ACID; UNCLASSIFIED DRUG;

ARTICLE; AUTISM; CHILD; CLINICAL ARTICLE; GAS CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT DURATION; URINALYSIS; URINARY EXCRETION; VITAMIN SUPPLEMENTATION;

ADIPIC ACIDS; AUTISTIC DISORDER; CAPRYLATES; CHILD; CHILD, PRESCHOOL; CREATININE; DICARBOXYLIC ACIDS; DIETARY SUPPLEMENTS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MAGNESIUM; RIBOFLAVIN; SUCCINIC ACID; TRACE ELEMENTS; VITAMIN B 6; VITAMIN B COMPLEX;

EID: 80051597730     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2011.06.002     Document Type: Article

References (50)

1. Manning-Courtney P., Brown J., Molloy C.A., Reinhold J., Murray D. Diagnosis and treatment of autism spectrum disorders. Cur Prob Ped Adol Health 2003, 33:283-304.
2. Johnson C.P., Myers S.M. Identification and evaluation of children with autism spectrum disorders. Pediatrics 2007, 120:1183-1215.
3. White J.F. Intestinal pathophysiology in autism. Exp Biol Med 2003, 228:639-649.
4. KałuŻna-CzapliŃska J., Socha E., Rynkowski J. Determination of homovanillic acid and vanillylmandelic acid in urine of autistic children by gas chromatography/mass spectrometry. Med Sci Monit 2010, 16:445-450.
5. Baieli S., Pavone L., Meli C., Fiumara A., Coleman M. Autism and phenylketonuria. J Autism Dev Disord 2003, 33:201-204.
6. Kotsopoulos S., Kutty K.M. Histidinemia and infantile autism. J Autism Dev Disord 1979, 9:55-60.
7. Van Kuilenburg A.B., Dobritzsch D., Meinsma R., Haasjes J., Waterham H.R., Nowaczyk M.J., et al. Novel disease-causing mutations in the dihydropyrimidine dehydrogenase gene interpreted by analysis of the three-dimensional protein structure. Biochem J 2002, 364:157-163.
8. Page T., Yu A., Fontanesi J., Nyhan W.L. Developmental disorder associated with increased cellular nucleotidase activity. Proc Natl Acad Sci U S A 1997, 94:11601-11606.
9. Weissman J.R., Kelley R.I., Bauman M.L., Cohen B.H., Murray K.F., Mitchell R.L., et al. Mitochondrial disease in autism spectrum disorder patients: a cohort analysis. PLoS One 2008, 3:e3815.
10. Gottschall E. Digestion-gut-autism connection: the Specific Carbohydrate Diet. Medical Veritas 2004, 1:261-271.
11. Bidet B., Leboyer M., Descours B., Bouvard M.P., Benveniste J. Allergic sensitization in infantile autism. J Autism Dev Disord 1993, 23:419-420.
12. Jyonouchi H. Food allergy and autism spectrum disorders: is there a link?. Curr Allergy Asthma Rep 2009, 9:194-201.
13. Curtin C., Anderson S.E., Must A., Bandini L. The prevalence of obesity in children with autism: a secondary data analysis using nationally representative data from the National Survey of Children's Health. BMC Pediatr 2010, 23:10-11.
14. Curtis L.T., Patel K. Nutritional and environmental approaches to preventing and treating autism and attention deficit hyperactivity disorder (ADHD): a review. J Altern Complement Med 2008, 14:79-85.
15. Adams J.B., Holloway C. Pilot study of a moderate dose multivitamin/mineral supplement for children with autistic spectrum disorder. J Altern Complement Med 2004, 10:1033-1039.
16. KałuŻna-CzapliŃska J., Michalska M., Rynkowski J. Determination of tryptophan in urine of autistic and healthy children by gas chromatography/mass spectrometry. Med Sci Monit 2010, 16:488-492.
17. KałuŻna-CzapliŃska J., Michalska M., Socha E., Błaszczyk S., Rozetti-Szymańska A., Rynkowski J. Nutritional deficiencies in children an example of autistic children. Nowa Pediatria 2009, 4:94-100.
18. Xia W., Zhou Y., Sun C., Wang J., Wu L. A preliminary study on nutritional status and intake in Chinese children with autism. Eur J Pediatr 2010, 169:1201-1206.
19. Lakshmi Priya M.D., Geetha A. Level of trace elements (copper, zinc, magnesium and selenium) and toxic elements (lead and mercury) in the hair and nail of children with autism. Biol Trace Elem Res 2010.
20. Marlowe M., Cossairt A., Stellern J., Errera J. Decreased magnesium in the hair of autistic children. J Orthomol psychiatry 1984, 13:117-122.
21. Volkmar F., Pauls D. Autism. Lancet 2003, 362:1133-1141.
22. Vianey-Liaud C., Divry P., Gregersen N., Mathieu M. The inborn errors of mitochondrial fatty acid oxidation. J Inherit Metab Dis 1987, 10:159-200.
23. Kumps A., Duez P., Mardens Y. Metabolic, nutritional, iatrogenic, and artifactual sources of urinary organic acids: a comprehensive table. Clin Chem 2002, 48:708-717.
24. Bralley J., Lord R. Organic acids. Laboratory evaluations in molecular medicine: nutrients, toxicants, and cell regulators 2001, 175-208. The Institute for Advances in Molecular Medicine, Norcross, GA.
25. Pieczenik S.R., Neustadt J. Mitochondrial dysfunction and molecular pathways of disease. Exp Mol Pathol 2007, 83:84-92.
26. Triggs W.J., Roe C.R., Rhead W.J., Hanson S.K., Lin S.N., Willmore L.J. Neuropsychiatric manifestations of defect in mitochondrial beta oxidation response to riboflavin. J Neurol Neurosurg Psychiatry 1992, 55:209-211.
27. Kurian M.A., Ryan S., Besley G.T., Wanders R.J., King M.D. Straight-chain acyl-CoA oxidase deficiency presenting with dysmorphia, neurodevelopmental autistic-type regression and a selective pattern of leukodystrophy. J Inherit Metab Dis 2004, 27:105-108.
28. KałuŻna-CzapliŃska J. Noninvasive urinary organic acids test to assess biochemical and nutritional individuality in autistic children. Clin Biochem 2011, 44:686-691.
29. American Psychiatric Association Diagnostic and statistical manual of mental disorders 1994, American Psychiatric Association, Washington. 4th ed.
30. Portaluppi F., Touitou Y., Smolensky M.H. Ethical and methodological standards for laboratory and medical biological rhythm research. Chronobiol Int 2008, 25:999-1016.
31. Kuśmierek K., Głowacki R., Bald E. Analysis of urine for cysteine, cysteinylglycine, and homocysteine by high-performance liquid chromatography. Anal Bioanal Chem 2006, 385:855-860.
32. Duran M., Beemer F.A., Tibosch A.S., Bruinvis L., Ketting D., Wadman S.K. Inherited 3-methylglutaconic aciduria in two brothers-another defect of leucine metabolism. J Pediatr 1982, 101:551-554.
33. Destefano F., Bhasin T.K., Thompson W.W., Yeargin-Allsopp M., Boyle C. Age at first measles-mumps-rubella vaccination in children with autism and school-matched control subjects: a population-based study in metropolitan Atlanta. Pediatrics 2004, 113:259-266.
34. Goodman S.I. Organic aciduria in the riboflavin-deficient rat. Am J Clin Nutr 1981, 34:2434-2437.
35. Chez M.G., Buchanan C.P., Aimonovitch M.C., Becker M., Schaefer K., Black C., et al. Double-blind, placebo-controlled study of l-carnosine supplementation in children with autistic spectrum disorders. J Child Neurol 2002, 17:833-837.
36. Eby G.A., Eby K.L. Magnesium for treatment-resistant depression: a review and hypothesis. Med Hypotheses 2010, 74:649-660.
37. Eby G.A., Eby K.L. Rapid recovery from major depression using magnesium treatment. Med Hypotheses 2006, 67:362-370.
38. De Valk H.W. Magnesium in diabetes mellitus. Neth J Med 1999, 54:139-146.
39. Jee S.H., Miller E.R., Guallar E., Singh V.K., Appel L.J., Klag M.J. The effect of magnesium supplementation on blood pressure: a meta-analysis of randomized clinical trials. Am J Hypertens 2002, 15:691-696.
40. Hodgkinson E., Neville-Webbe H.L., Coleman R.E. Magnesium depletion in patients receiving cisplatin-based chemotherapy. Clin Oncol (R Coll Radiol) 2006, 18:710-718.
41. Mousain-Bosc M., Roche M., Rapin J., Bali J.P. Magnesium VitB6 intake reduces central nervous system hyperexcitability in children. J Am Coll Nutr 2004, 23:545-548.
42. Strambi M., Longini M., Hayek J., Berni S., Macucci F., Scalacci E., et al. Magnesium profile in autism. Biol Trace Elem Res 2006, 109:97-104.
43. Martineau J., Barthelemy C., Cheliakine C., Lelord G. Brief report: an open middle-term study of combined vitamin B6-magnesium in a subgroup of autistic children selected on their sensitivity to this treatment. J Autism Dev Disord 1988, 18:435-447.
44. Rimland B. Puberty, aggression, and seizures. Autism Res Rev Int 2005, 19:3.
45. Pfeiffer S.I., Norton J., Nelson L., Shott S. Efficacy of vitamin B6 and magnesium in the treatment of autism: a methodology review and summary of outcomes. J Autism Dev Disord 1995, 25:481-493.
46. Rossignol D.A. Novel and emerging treatments for autism spectrum disorders: a systematic review. Ann Clin Psychiatry 2009, 21:213-236.
47. Lelord G., Muh J.P., Barthelemy C., Martineau J., Garreau B., Callaway E. Effects of pyridoxine and magnesium on autistic symptoms-initial observations. J Autism Dev Disord 1981, 11:219-230.
48. Shaw W., Kassen E., Chaves E. Increased excretion of analogs of Krebs cycle metabolites and arabinose in two brothers with autistic features. Clin Chem 1995, 41:1094-1104.
49. Shaw W. Oxalates control is a major new factor in autism therapy 2006, The Great Plains Laboratory, Lenexa, KS, USA.
50. Shaw W., Kassen E., Chaves E. Assessment of antifungal drug therapy in autism by measurement of suspected microbial metabolites in urine with gas chromatography-mass spectrometry. Clin Prac Alter Med 2000, 1:15-26.